Peripheral immune pathway linked to neurodegeneration in tauopathy mice

Researchers at Washington University School of Medicine in St. Louis investigated whether immune signals outside the brain drive T-cell accumulation and neurodegeneration in mice modeling tau-related disease. The study, reported in Nature Neuroscience on September 3, focused on classical dendritic cells type 1 (cDC1), which help activate T cells. The source did not report animal numbers or quantitative effect sizes.

Eliminating dendritic cells from lymph nodes and other sites largely removed the excess brain T cells, particularly CD8 T cells, and reduced associated neurodegeneration. Cognitive abilities were preserved, although the amount of tau tangles did not change. These findings suggest that immune-mediated damage can be modified independently of tau tangle burden in this model.

The activating signal remains unknown. The researchers hypothesize that material released by tau-damaged brain cells reaches neck lymph nodes, where dendritic cells present it to T cells. A peripheral target could potentially avoid the need for drugs to cross the blood–brain barrier, but therapeutic efficacy in humans has not been established. Importantly, dendritic cells were blocked from birth; the team is now testing intervention around the onset of tau pathology in midlife. This account is based on university-provided material rather than a detailed appraisal of the study.